Pharmacokinetic data analysis using Phoenix WinNonlin and other data analysis tool. Collection of different vital organs during tissue distribution studies in rodents. 
Chronic bile duct cannulations in rat and various animal models used for in vivo pharmacokinetics studies.
Well versed with surgical procedures like cannulation of jugular, femoral, portal vein in rats. Compliance to Syngene’ s quality standards at all times. Adherence to all procedures related to Syngene’ s data integrity policies. Adherence to all environment, health, and safety (EHS) policies & standards at all times in the workplace. Understanding and demonstrating responsibility for safety of self & colleagues by following all safety protocols provided by Syngene. Ability to adapt to the dynamic team environment. Documenting the lab notebooks online and compound management. Preparation of study protocols, reports for IND/ NDA submissions. Conduct of pharmacokinetic studies in rodents. Ability to adapt to the dynamic team environment. The candidate will be a part of the Discovery Biology-DMPK group, looking for a candidate who is well versed with In vivo pharmacokinetics & to conduct study in rodents. Posts: Associate Scientist - DMPK In vivo Pharmacokinetics, Associate Scientist Bioanalytical, Senior Associate Scientist -Invitro ADME BioanalystĪssociate Scientist - DMPK In vivo Pharmacokinetics (36343) Its innovative culture is driven by the passion of its 4240- strong team of scientists who work with clients from around the world to solve their scientific problems, improve R&D productivity, speed up time to market and lower the cost of innovation. Syngene’ s clientele includes world leaders such as Bristol-Myers Squibb, Baxter, Amgen, GSK, Merck KGaA and Herbalife. is an innovation-focused global discovery, development and manufacturing organization providing integrated scientific services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries around the world. Incorporated in 1993, Syngene International Ltd.
0 kommentar(er)
